Effects of fenofibrate on acute myocardial ischemic damage induced by isoproterenol: experiment with rats

BO Hai,HE Wei,LIU Zi-quan

DOI: https://doi.org/10.3969/j.issn.1673-6966.2008.05.003

2008-01-01

Abstract:Objective To investigate the effects of fenofibrate (FF), a peroxisome proliferator- activator receptor α (PPAR-α) activator on the cardiac injury caused by myocardial ischemia and mechanism thereof. Methods Forty-eight male SD rats were randomly divided into 3 equal groups: isoproterenol (ISO) group and control group both undergoing gastric lavage of normal saline (NS) 20 ml/kg once a day for 7d, and FF pretreatment group, undergoing gastric lavage of FF solved in NS 20 ml/kg once a day for 7d.One hour after the last lavage the FF and ISO groups underwent intraperitoneal injection of ISO 5 mg/kg, and the control group underwent intrapeitoneal injection of NS. 24 h later blood samples was obtained by picking out the eyeball to isolate serum. And then the hearts were taken out for measurement of heart weight (HW), pathology of the myocardium, and calculation of the HW/body weight (BW)% and infarction size (IS)/ventricular weight (VW)%. Nitrate reductase method and double antibody sandwich ELISA were used to detect the serum nitrogen oxide (NO) and tumor necrosis factor ( TNF)-α. Sodium dodecyl sulfate polyacrylamide gel electrophoresis was used to examine the PPARα protein expression in the myocardium. Results The HW/BW of the ISO group was (6.71±0.55) mg/g, significantly higher than that of the control group [(4.05±0.37) mg/g, P<0.01], and the HW/BW of the FF group was (5.28±0.49) mg/g, significantly lower than that of the ISO group (P <0.05) and still significantly higher than that of the control group (P <0.05). The IS/VW% of the ISO group was (0.75±0.09)%, significantly higher than that of the control group [(0.07±0.02)%, P <0.01]; and the IS/VW% of the FF group was (0.31±0.08)%, significantly lower than that of the ISO group (P <0.01) and still significantly higher than that of the control group (P <0.01). The serum NO level of the ISO group was (20.79±5.95) μmol/L, significantly lower than that of the control group [(49.65±6.97)μmol/L, P <0.01], and the serum NO level of the FF group was (80.45±11.61) μmol/L, significantly higher than those of the control and ISO groups (both P <0.01). The serum TNF-α level of the ISO group was (275.41±27.61)%, significantly higher than that of the control group [(20.01±3.29)%, P <0.01]; and the serum TNF-α level of the FF group was (149.07±22.39)%, significantly lower than that of the ISO group (P <0.01), but still significantly higher than that of the control group (P <0.01). The PPARα protein expression level of the ISO group was significantly lower than that of the control group (P <0.05), and the PPARα protein expression level of the FF group was significantly higher than those of the ISO and control groups (both P <0.05). Conclusion FF reduces the cardiac infarction area and protects the heart from ischemic injury via activating PPARα.